R&G PharmaStudies (301333.SZ) shareholders Harmony Growth Phase II and Harmony Health plan to reduce their holdings by no more than 2.56 million shares.

14/11/2024

GMT Eight

R&G PharmaStudies (301333.SZ) announces that shareholders Harmony Growth Phase II and Harmony Health intend to reduce their holdings in the company, with a total quantity not exceeding 2,560,000 shares.

Zhejiang JIULI Hi-tech Metals (002318.SZ) obtained a commitment from the Construction Bank Huzhou Branch to repurchase special loans of no more than 200 million yuan.

Ningbo Peacebird Fashion (603877.SH) controlling shareholder plans to increase their holdings of company shares by 1.5 billion to 3 billion yuan.

Contact: contact@gmteight.com

R&G PharmaStudies (301333.SZ) shareholders Harmony Growth Phase II and Harmony Health plan to reduce their holdings by no more than 2.56 million shares.

RECOMMEND

Steady pace of transformation, Lenovo (00992) SSG has achieved double-digit growth for 14 consecutive quarters.

Servers, storage, and software all saw significant increases, with Lenovo's ISG second quarter profits skyrocketing by 65%.

A-share pre-market report | 6G welcomes new progress! Huawei inaugurates the Intelligent Manufacturing Innovation Center